Brief: Nikkei Says Kobayashi Pharma Chairman And President To Resign Due To Deadly Supplement

Kobayashi Pharmaceutical

22/07/2024 13:24

July 22 (Reuters) - Nikkei:
    * KOBAYASHI PHARMA CHAIRMAN AND PRESIDENT TO RESIGN DUE TO
DEADLY
SUPPLEMENT 
    * SENIOR EXECUTIVE DIRECTOR SATOSHI YAMANE IS EXPECTED TO
BECOME
PRESIDENT OF KOBAYASHI PHARMA
    * KOBAYASHI PHARMACEUTICAL’S CHAIRMAN, KAZUMASA KOBAYASHI,
AND ITS
PRESIDENT, AKIHIRO KOBAYASHI, WILL RESIGN
    * PRESIDENT AKIHIRO KOBAYASHI WILL GIVE UP THE AUTHORITY TO
REPRESENT KOBAYASHI PHARMACEUTICAL BUT REMAIN AS A DIRECTOR


Further company coverage:  4967.T 

 ((Reuters.Briefs@thomsonreuters.com;))